299 related articles for article (PubMed ID: 9284826)
21. Somatostatin receptor subtype gene expression in pituitary adenomas.
Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
[TBL] [Abstract][Full Text] [Related]
22. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
23. Presence of GHRH mRNA in human pituitary somatotrophinomas and its relationship to in vitro effect of a GHRH-antagonist on GH secretion and cAMP production.
Adams EF; Law H; Buchfelder M; Fahlbusch R; Lightman S; Levy A
Pituitary; 1998 Apr; 1(1):7-12. PubMed ID: 11081178
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone releasing hormone-sensitive adenylate cyclase activity in growth hormone-producing pituitary adenoma: correlation to the response of plasma growth hormone to growth hormone releasing hormone in patients with acromegaly.
Natori S; Ikuyama S; Haji M; Ohashi M; Nawata H
Endocrinol Jpn; 1989 Apr; 36(2):229-36. PubMed ID: 2550207
[TBL] [Abstract][Full Text] [Related]
25. Effects of growth hormone-releasing hormone (GHRH) on densely granulated somatotroph adenomas and sparsely granulated somatotroph adenomas in vitro: a morphological and functional investigation.
Kawakita S; Asa SL; Kovacs K
J Endocrinol Invest; 1989; 12(7):443-48. PubMed ID: 2551950
[TBL] [Abstract][Full Text] [Related]
26. Transcript abundance in mouse pituitaries with altered growth hormone expression quantified by reverse transcriptase polymerase chain reaction implicates transcription factor Zn-16 in gene regulation in vivo.
Wojtkiewicz PW; Phelps CJ; Hurley DL
Endocrine; 2002 Jun; 18(1):67-74. PubMed ID: 12166626
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide.
Renner U; Brockmeier S; Strasburger CJ; Lange M; Schopohl J; Müller OA; von Werder K; Stalla GK
J Clin Endocrinol Metab; 1994 May; 78(5):1090-6. PubMed ID: 8175966
[TBL] [Abstract][Full Text] [Related]
28. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy.
Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G
J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356
[TBL] [Abstract][Full Text] [Related]
29. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
[TBL] [Abstract][Full Text] [Related]
30. Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly.
Ikuyama S; Natori S; Nawata H; Kato K; Ibayashi H; Kariya T; Sakai T; Rivier J; Vale W
J Clin Endocrinol Metab; 1988 Jun; 66(6):1265-71. PubMed ID: 2836473
[TBL] [Abstract][Full Text] [Related]
31. Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex).
Pack SD; Kirschner LS; Pak E; Zhuang Z; Carney JA; Stratakis CA
J Clin Endocrinol Metab; 2000 Oct; 85(10):3860-5. PubMed ID: 11061550
[TBL] [Abstract][Full Text] [Related]
32. Expression of corticotropin-releasing hormone messenger ribonucleic acid in human pituitary corticotroph adenomas associated with proliferative potential.
Xu B; Sano T; Yamada S; Li CC; Hirokawa M
J Clin Endocrinol Metab; 2000 Mar; 85(3):1220-5. PubMed ID: 10720066
[TBL] [Abstract][Full Text] [Related]
33. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors.
Adams EF; Brockmeier S; Friedmann E; Roth M; Buchfelder M; Fahlbusch R
Neurosurgery; 1993 Aug; 33(2):198-203; discussion 203. PubMed ID: 8396223
[TBL] [Abstract][Full Text] [Related]
34. Effects of single and short-term administration of clonidine on hypothalamic-pituitary somatotropic function of the adult male rat: an in situ hybridization study.
De Gennaro Colonna V; Zoli M; Settembrini BP; Ciceri S; De Marco A; Cella SG; Agnati LF; Muller EE
J Pharmacol Exp Ther; 1996 Feb; 276(2):795-800. PubMed ID: 8632352
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological Features of Growth Hormone-producing Pituitary Adenomas and Correlation With Preoperative Laboratory Findings.
Burcea IF; Năstase VN; Cîmpean AM; Ceaușu AR; Baciu I; Căpățînă C; Dusceac R; Găloiu S; Niculescu D; Radian Ș; Trifănescu R; Dumitrașcu A; Cocoșilă LC; Raica M; Poiană C
Anticancer Res; 2021 May; 41(5):2669-2680. PubMed ID: 33952498
[TBL] [Abstract][Full Text] [Related]
36. Absence of mutations in the growth hormone (GH)-releasing hormone receptor gene in GH-secreting pituitary adenomas.
Salvatori R; Thakker RV; Lopes MB; Fan X; Eswara JR; Ellison D; Lees P; Harding B; Yang I; Levine MA
Clin Endocrinol (Oxf); 2001 Mar; 54(3):301-7. PubMed ID: 11298081
[TBL] [Abstract][Full Text] [Related]
37. Partial reversibility of growth hormone (GH) deficiency in the GH-releasing hormone (GHRH) knockout mouse by postnatal treatment with a GHRH analog.
Alba M; Schally AV; Salvatori R
Endocrinology; 2005 Mar; 146(3):1506-13. PubMed ID: 15564325
[TBL] [Abstract][Full Text] [Related]
38. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
[TBL] [Abstract][Full Text] [Related]
39. Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.
Lloyd RV; Cano M; Chandler WF; Barkan AL; Horvath E; Kovacs K
Am J Pathol; 1989 Mar; 134(3):605-13. PubMed ID: 2466405
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
